Alliance Wealth Advisors, LLC /Ut Halozyme Therapeutics, Inc. Transaction History
Alliance Wealth Advisors, LLC /Ut
- $380 Billion
- Q3 2024
A detailed history of Alliance Wealth Advisors, LLC /Ut transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Alliance Wealth Advisors, LLC /Ut holds 19,893 shares of HALO stock, worth $957,450. This represents 0.3% of its overall portfolio holdings.
Number of Shares
19,893
Previous 13,527
47.06%
Holding current value
$957,450
Previous $708 Million
60.77%
% of portfolio
0.3%
Previous 0.21%
Shares
6 transactions
Others Institutions Holding HALO
# of Institutions
543Shares Held
125MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$848 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$621 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$319 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$196 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$164 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $6.7B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...